Saltar al contenido
Salud cardiovascularEstudio de cohorte3 min read

AI reading of a routine ECG predicts who will develop high blood pressure

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Artificial Intelligence-Enhanced Electrocardiography for Prediction of Incident Hypertension. · JAMA cardiology · 2025 · Artículo original ↗

Idea principal

An AI model reading routine ECGs (AIRE-HTN) predicted new-onset hypertension with a C index of 0.70 (95% CI 0.69-0.71) in both a Boston hospital cohort and the UK Biobank. That is moderate discrimination in two non-general-population cohorts, so it is a research tool, not a screening test.

Study design

Estudio de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Hypertension drives large amounts of illness and death, and early lifestyle changes and treatment help, so spotting who will develop it could allow earlier prevention. The authors built an AI-ECG risk estimator, AIRE-HTN, to predict incident hypertension and to sort people by risk of related complications.

Población y método

Development and external validation prognostic cohort study. The model, a residual convolutional neural network with a discrete-time survival loss function, was trained on 1 163 401 ECGs from 189 539 patients (mean age 57.7, SD 18.7 years; 98 747 female [52.1%]) at Beth Israel Deaconess Medical Center (BIDMC) in Boston from 2014 to 2023. A test set of 19 423 BIDMC patients was evaluated, and external validation used 65 610 ECGs from UK Biobank participants (mean age 65.4, SD 7.9 years; 33 785 female [51.5%]), of whom 35 806 were evaluated for incident hypertension.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    AIRE-HTN predicted incident hypertension with a C index of 0.70 (95% CI 0.69-0.71) in BIDMC (6446 events, 33%) and 0.70 (95% CI 0.69-0.71) in UK Biobank (1532 events, 4%).
  2. 2
    Performance held in people without left ventricular hypertrophy and with normal ECGs (C indices 0.67-0.72).
  3. 3
    It added to existing clinical risk factors (continuous net reclassification index 0.44, 95% CI 0.33-0.53 at BIDMC; 0.32, 95% CI 0.23-0.37 in UK Biobank).
  4. 4
    The score independently predicted cardiovascular death (HR 2.24 per standard deviation, 95% CI 1.67-3.00) and stratified risk of heart failure (HR 2.60), myocardial infarction (HR 3.13), ischemic stroke (HR 1.23) and chronic kidney disease (HR 1.89), beyond traditional risk factors.

Límites e incertidumbre

  1. 1
    A C index of 0.70 means moderate ability to rank who develops hypertension, and the abstract does not report calibration or how many cases would be missed or flagged wrongly.
  2. 2
    Development used a secondary-care hospital population, where people have ECGs for a reason; the UK Biobank is a volunteer cohort, so neither represents the general public.
  3. 3
    The event rates differ widely (33% at BIDMC versus 4% in UK Biobank), reflecting different populations and follow-up, so the numbers are not directly comparable.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

The model suggests a standard 12-lead ECG holds hidden information about future blood pressure problems, and it may someday help target prevention. It is not available as a consumer test, and a score does not mean you will or will not develop hypertension. Blood pressure questions belong with your clinician.

Tus datos

The model reads clinical ECGs, not a smartwatch tracing. A better personal link is blood pressure measured with a validated cuff: take readings at the same time of day, seated and rested, and compare averages over weeks rather than single readings.

Cómo interpretar la evidencia

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Importance

Hypertension underpins significant global morbidity and mortality. Early lifestyle intervention and treatment are effective in reducing adverse outcomes. Artificial intelligence-enhanced electrocardiography (AI-ECG) has been shown to identify a broad spectrum of subclinical disease and may be useful for predicting incident hypertension.

Objective

To develop an AI-ECG risk estimator (AIRE) to predict incident hypertension (AIRE-HTN) and stratify risk for hypertension-associated adverse outcomes.

Design, setting, and participants

This was a development and external validation prognostic cohort study conducted at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, a secondary care setting. External validation was conducted in the UK Biobank (UKB), a UK-based volunteer cohort. AIRE-HTN was trained and tested to predict incident hypertension using routinely collected ECGs from patients at BIDMC between 2014 and 2023. The algorithm was then evaluated to risk stratify patients for hypertension- associated adverse outcomes and externally validated on UKB data between 2014 and 2022 for both incident hypertension and risk stratification.

Main outcomes and measures

AIRE-HTN, which uses a residual convolutional neural network architecture with a discrete-time survival loss function, was trained to predict incident hypertension.

Results

AIRE-HTN was trained on 1 163 401 ECGs from 189 539 patients (mean [SD] age, 57.7 [18.7] years; 98 747 female [52.1%]) at BIDMC. A total of 19 423 BIDMC patients composed the test set and were evaluated for incident hypertension. From the UKB, AIRE-HTN was tested on 65 610 ECGs from same number of participants (mean [SD] age, 65.4 [7.9] years; 33 785 female [51.5%]). A total of 35 806 UKB patients were evaluated for incident hypertension. AIRE-HTN predicted incident hypertension (BIDMC: n = 6446 [33%] events; C index, 0.70; 95% CI, 0.69-0.71; UKB: n = 1532 [4%] events; C index, 0.70; 95% CI, 0.69-0.71). Performance was maintained in individuals without left ventricular hypertrophy and those with normal ECGs (C indices, 0.67-0.72). AIRE-HTN was significantly additive to existing clinical risk factors in predicting incident hypertension (continuous net reclassification index, BIDMC: 0.44; 95% CI, 0.33-0.53; UKB: 0.32; 95% CI, 0.23-0.37). In adjusted Cox models, AIRE-HTN score was an independent predictor of cardiovascular death (hazard ratio [HR] per standard deviation, 2.24; 95% CI, 1.67-3.00) and stratified risk for heart failure (HR, 2.60; 95% CI, 2.22-3.04), myocardial infarction (HR, 3.13; 95% CI, 2.55-3.83), ischemic stroke (HR, 1.23; 95% CI, 1.11-1.37), and chronic kidney disease (HR, 1.89; 95% CI, 1.68-2.12), beyond traditional risk factors.

Conclusions and relevance

Results suggest that AIRE-HTN, an AI-ECG model, can predict incident hypertension and identify patients at risk of hypertension-related adverse events, beyond conventional clinical risk factors.

Fuentes y atribución

Artificial Intelligence-Enhanced Electrocardiography for Prediction of Incident Hypertension.

Sau A, Barker J, Pastika L, Sieliwonczyk E, Patlatzoglou K, McGurk KA, Peters NS, O'Regan DP, Ware JS, Kramer DB, Waks JW, Ng FS.

JAMA cardiology · 2025-03-01

DOI: 10.1001/jamacardio.2024.4796 ↗PubMed · 39745684 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis observacional

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Salud cardiovascular →